PTW-002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PTW-002, covering 2023-03-31 to 2023-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene [Phase 1, Phase 2]